INDIAN
MARKET
ALPHA.
200
Stocks Tracked
10
Sectors
+127%
Portfolio Yield
+33%
Benchmark
The 3-year cumulative returns reveal deep structural divergences. Metal (+162%) and Pharma (+108%) dictated the bull cycle while Media struggled with legacy headwinds.
Commodity super-cycle & infrared demand.
Domestic healthcare expansion surge.
Digital transition attrition (-1.3%).
Performance consistency varies. Realty observed a momentum peak in mid-2024, whereas IT faced global macro headwinds into 2025.
Hit +175% in mid-2024 but corrected back to +77% by year end.
Rallied strongly early on but faced U.S. tech spending slowdown.
Mapping CAGR against standard deviation. Bubble size represents the Sharpe Ratio. Efficiency clusters in the upper-left gradient.
Sit upper-left - best Sharpe ratios (0.90 and 0.80) with high reward.
High returns but even higher volatility - not an efficient bet.
Lower-right placement: high risk combined with negative return.
The Sharpe Ratio defines risk-adjusted performance ((CAGR - Risk-Free Rate) / Volatility). We used the Indian 10-year bond yield (7%) as the risk-free baseline.
8 out of 10 sectors recorded a positive Sharpe, effectively rewarding risk.
Scored 0.90 - nearly 1 unit of return generated per unit of risk taken.
Diversification requires low correlation coefficients. FMCG acts as the primary systemic hedge across all simulated clusters.
Lowest correlation with all sectors - the ultimate defensive diversifier.
Banking+FinServ and Metal+Energy both show high correlation (0.79) - essentially moving as unified blocks.
Low cross-correlation - pairing them reduces overall portfolio volatility.
Executing 5,000 algorithmic permutations to identify the hyper-efficient tangency point on the frontier curve.
The gold star portfolio - best possible risk-adjusted return across 5,000 sims.
The leftmost blue dot - the absolute lowest risk portfolio possible.
Notice the curve - adding risk above the tangency point buys progressively less return.
The covariance and Monte Carlo models output our final weights: an optimized balance of growth and defensive assets designed to maximize the Sharpe Ratio.
Highest weight allocated due to its superior risk-adjusted consistency.
Strong absolute returns with low correlation to our Pharma anchor.
Mathematically eliminated - low returns simply didn't justify the allocation.
Optimal allocation consistently outputs alpha. +127% Cumulative Return vs Benchmark at +33%.
Our dynamic rotation yielded +127% vs the NIFTY 50's +33%.
The performance gap materialized as Pharma and Metal diverged from the broader index.
The portfolio maintained its absolute lead even during sharp market drawdowns.